Crispr Therapeutics shares tumble after significant earnings miss
Investing.com -- 3M Co. reported first-quarter 2025 results that exceeded analyst expectations, driven by organic sales growth and improved margins.
3M posted adjusted earnings per share of $1.88 for the quarter, surpassing the analyst consensus of $1.75. Revenue came in at $5.8 billion, slightly above estimates of $5.78 billion and up 0.8% YoY. Adjusted organic sales grew 1.5% YoY.
The company’s adjusted operating margin expanded to 23.5%, an increase of 220 basis points from the prior year. 3M attributed the margin improvement to cost reduction initiatives and pricing actions.
"We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and CEO.
For the full year 2025, 3M sees its adjusted EPS between $7.60 to $7.90, compared to the analyst consensus of $7.75. However, the company noted potential tariff impacts could reduce EPS by $0.20 to $0.40.
3M’s stock edged up 0.7% following the earnings release.
The company returned $1.7 billion to shareholders through dividends and share repurchases during the quarter. 3M reported negative operating cash flow of $0.1 billion, but generated adjusted free cash flow of $0.5 billion.